The prevalence of use, dependency and harms of legal 'party pills' containing benzylpiperazine (BZP) and trifluorophenylmethylpiperazine (TFMPP) in New Zealand

Journal of Substance Use

Volumn 12, Issue 3, 2007, Pages 213-224

  Wilkins, Chris ^a   Girling, Melissa ^a   Sweetsur, Paul ^a  

^a MASSEY UNIVERSITY   (New Zealand)

Author keywords

BZP; Population survey; TFMPP

Indexed keywords

1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 1 BENZYLPIPERAZINE DERIVATIVE; ILLICIT DRUG;

ADOLESCENT; ADULT; ARTICLE; DEPRESSION; DRUG DEPENDENCE; DRUG MARKETING; DRUG USE; FEMALE; GOVERNMENT REGULATION; HOUSEHOLD; HUMAN; INSOMNIA; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; NEW ZEALAND; PARANOIA; PILL; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SEIZURE; THORAX PAIN; VISUAL HALLUCINATION; VOMITING;

EID: 34250632332     PISSN: 14659891     EISSN: 14759942     Source Type: Journal    
DOI: 10.1080/14659890701288945     Document Type: Article

References (30)

1. Aitchison, L. and Hughes, R. (2006) Treatment of adolescent rats with 1-benzylpiperazine: A preliminary study of subsequent behavioral effects. Neurotoxicology and Teratology, 28, pp. 453-458.
2. Alansari, M. and Hamilton, D. (2006) Nephrotoxicity of BZP-based herbal party pills: A New Zealand case report. New Zealand Medical Journal, 119, p. 1959.
3. Austin, H. and Monasterio, E. (2004) Acute psychosis following ingestion of 'Rapture'. Australasian Psychiatry, 12, pp. 406-408.
4. Baumann, M., Clark, R., Budzynski, A., Partilla, J., Blough, B. and Rothman, K. (2004) Effects of 'Legal X' piperazine analogs on dopamine and serotonin release in rat brain. Annals of the New York Academy of Sciences, 1025, pp. 189-197.
5. Baumann, M., Clark, R., Budzynski, A., Partilla, J., Blough, B. and Rothman, K. (2005) N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy'). Neuropsychopharmacology, 30, pp. 550-560.
6. Blundell, S. (2005) Pop until you drop. New Zealand Listener, 199
7. Bye, C., Munro-Faure, A., Peck, A. and Young, P. (1973) A comparison of the effects of l-benzylpiperazine on human performance tests. European Journal of Clinical Pharmacology, 6, pp. 163-169.
8. Campbell, H., Cline, W. and Evans, M. (1973) Comparison of the effects of dexamethamphetamine and l-benzylpiperazine in former addicts. European Journal of Clinical Pharmacology, 6, pp. 170-176.
9. de Boer, D., Bosman, I., Hidvegi, E., Manzoni, C., Benko, A., Reys, J. dos and Maes, R. (2005) Piperazine-like compounds: A new group of designer drugs of abuse on the European market. Neuropsychopharmacology, 30, pp. 550-560.
10. Drug Enforcement Administration (DEA) Department of Justice Schedules of controlled substances; placement of 2,5-dimethoxy-4-(n)-propylthiophenethylamine and N-benzylpiperazine into Schedule I of the Controlled Substances Act. Final rune. Federal Register, pp. 12794-12797.
11. Expert Advisory Committee on Drugs The Expert Advisory Committee on Drugs (EACD) Advice to the Minister on: Benzylpiperazibe (BZP)
12. Fantegrossi, W., Winger, G., Woods, J., Woolverton, W. and Coop, A. (2005) Reinforcing and discriminative stimulus effects of 1-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys. Drug and Alcohol Dependence, 77, pp. 161-168.
13. Gee, P., Richardson, S., Woltersdorf, W. and Moore, G. (2005) Toxic effects of BZP-based herbal party pills in humans: A prospective study in Christchurch, New Zealand. New Zealand Medical Journal, 118, p. 1784.
14. Gossop, M., Darke, S., Griffiths, P., Hando, J., Powis, B., Hall, W. and Strang, J. (1995) The Severity of Dependence Scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction, 90, pp. 607-614.
15. Hall, W. and Hando, J. (1994) Route of administration and adverse effects of amphetamine use among young adults in Sydney, Australia. Drug and Alcohol Review, 13, pp. 277-284.
16. Herndon, J., Pierson, M. and Glennon, R. (1992) Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylyphenyl)piperazine. Pharmacology Biochemistry and Behavior, 43, pp. 739-748.
17. Janes, A. (2004) Party pills. New Zealand Listener
18. Kirby, T. (2006) Funk pills: Getting on a 'legal high'. Independent
19. Klee, H. (1997) A typology of amphetamine users in the United Kingdom. Amphetamine misuse: International perspectives on current trends, pp. 35-68. Harwood Academic Publishers, Amsterdam
20. Maurer, H., Kraemer, T., Springer, D. and Staack, R. (2004) Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (Ecstasy), piperazine, and pyrrolidinophene types: A synposis. Therapeutic Drug Monitoring, 26, pp. 127-131.
21. McCandless, D. (2005) Clubbers snap up new legal high. Guardian
22. Meririnne, E., Kajos, M., Kankaanpaa, A. and Seppala, T. (2006) Rewarding properties of 1-benzylpiperazine, a new drug of abuse, in rats. Basic & Clinical Pharmacology & Toxicology, 98, pp. 346-350.
23. Morgan, P. and Beck, J. (1997) The legacy and the paradox: Hidden contexts of methamphetamine misuse in the United States. Amphetamine misuse: International perspectives on current trends, pp. 135-162. Harwood Academic Publishers, Amsterdam
24. Nicholson, T. (2006) Prevalence of use, epidemillogy and toxicity of 'herbal party pills' among those presenting to the emergency department. Emergency Medicine Australasia, 18, pp. 180-184.
25. Sato, M., Chen, C., Akiyama, K. and Otsuki, S. (1983) Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biological Psychiatry, 18, pp. 429-440.
26. Saunders, A. (2005) Party pill user set room on fire. Dominion Post
27. Tsutsumi, H., Katagi, M., Miki, A., Shima, N., Kamata, T., Nakajima, K., Inoue, H., Kishi, T. and Tsuchihashi, H. (2006) Metabolism and the urinary excretion profile of the recently scheduled designer drug N-benzlypiperazine (BZP) in the rat. Journal of Analytical Toxicology, 30, pp. 38-43.
28. Vince, G. (2006) Legally high. New Scientist, 191:2571, pp. 40-45.
29. Wikstrom, M., Holmgren, P. and Ahlner, J. (2004) A2 (N-benzylpiperazine) a new drug of abuse in Sweden. Journal of Analytical Toxicology, 28, pp. 67-70.
30. Yates, K., O'Connor, A. and Horlsey, C. (2000) 'Herbal Ecstasy': A case series of adverse reactions. New Zealand Medical Journal, 113, pp. 315-317.